Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Jennifer Patnaik

Concepts (424)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Visual Acuity
30
2026
481
5.040
Why?
Cataract
18
2024
237
3.850
Why?
Macular Degeneration
16
2025
189
3.770
Why?
Geographic Atrophy
12
2025
97
3.560
Why?
Phacoemulsification
14
2025
120
2.590
Why?
Wet Macular Degeneration
7
2025
57
2.140
Why?
Registries
10
2025
2224
2.130
Why?
Diabetic Retinopathy
13
2024
204
2.090
Why?
Lenses, Intraocular
6
2022
49
1.850
Why?
Tomography, Optical Coherence
11
2025
261
1.790
Why?
Fluorescein Angiography
10
2026
182
1.730
Why?
Intraocular Pressure
12
2026
326
1.620
Why?
Ophthalmology
6
2025
115
1.450
Why?
Cataract Extraction
10
2024
118
1.390
Why?
Glaucoma
8
2025
250
1.160
Why?
Optometry
2
2025
9
1.130
Why?
Optometrists
2
2025
8
1.130
Why?
Retinopathy of Prematurity
4
2026
178
1.110
Why?
Keratomileusis, Laser In Situ
3
2024
20
1.100
Why?
Follow-Up Studies
26
2026
5276
1.080
Why?
Retinal Detachment
6
2023
70
0.970
Why?
Photorefractive Keratectomy
2
2024
21
0.950
Why?
Retrospective Studies
57
2026
16647
0.940
Why?
Fovea Centralis
1
2025
24
0.940
Why?
Acanthamoeba Keratitis
1
2025
4
0.930
Why?
Eye Infections, Parasitic
1
2025
6
0.930
Why?
Myopia
7
2024
59
0.920
Why?
Keratotomy, Radial
2
2022
10
0.910
Why?
Aged, 80 and over
29
2025
8009
0.910
Why?
Aged
50
2026
25297
0.810
Why?
Burnout, Professional
3
2025
469
0.810
Why?
Humans
122
2026
142675
0.790
Why?
Refraction, Ocular
6
2024
47
0.780
Why?
Capsule Opacification
2
2021
22
0.730
Why?
Intraoperative Complications
6
2024
154
0.720
Why?
Presbyopia
1
2022
15
0.710
Why?
Retinal Drusen
4
2024
31
0.710
Why?
Eye Diseases
2
2020
94
0.710
Why?
Uveitis
4
2025
147
0.700
Why?
Posterior Capsulotomy
1
2021
7
0.700
Why?
Posterior Capsule of the Lens
1
2021
11
0.700
Why?
Female
76
2026
76889
0.700
Why?
Trabeculectomy
5
2025
75
0.690
Why?
Lasers, Solid-State
1
2021
23
0.690
Why?
National Eye Institute (U.S.)
1
2020
6
0.670
Why?
Surveys and Questionnaires
13
2025
5952
0.670
Why?
Automobile Driving
2
2022
153
0.640
Why?
Colorado
22
2026
4569
0.640
Why?
Male
69
2026
71074
0.630
Why?
Glaucoma, Open-Angle
4
2023
104
0.620
Why?
Retinal Neovascularization
1
2019
28
0.620
Why?
Laser Therapy
1
2021
132
0.610
Why?
Dementia
1
2023
294
0.610
Why?
Vitrectomy
6
2025
72
0.590
Why?
Estrogen Replacement Therapy
1
2019
141
0.580
Why?
Middle Aged
38
2026
35224
0.570
Why?
Lens, Crystalline
1
2020
136
0.560
Why?
Postoperative Complications
6
2024
2869
0.560
Why?
Lasers, Excimer
3
2024
30
0.550
Why?
Metformin
1
2021
329
0.530
Why?
Angiogenesis Inhibitors
3
2026
232
0.530
Why?
Strabismus
3
2023
70
0.520
Why?
Complement Activation
5
2025
410
0.510
Why?
West Nile Fever
3
2011
56
0.510
Why?
Internal Medicine
1
2019
275
0.490
Why?
Emergency Medicine
1
2019
258
0.490
Why?
Laser Coagulation
3
2026
76
0.490
Why?
Refractive Errors
3
2025
36
0.480
Why?
Complement System Proteins
4
2025
311
0.470
Why?
Choroid
3
2025
78
0.470
Why?
Prevalence
7
2025
2805
0.460
Why?
Family Practice
1
2019
413
0.460
Why?
Cross-Sectional Studies
12
2025
5726
0.460
Why?
Self Report
2
2022
861
0.450
Why?
Breast Neoplasms
3
2011
2334
0.430
Why?
United States
19
2026
15496
0.420
Why?
Vascular Endothelial Growth Factor A
4
2026
555
0.420
Why?
Lens Implantation, Intraocular
5
2022
79
0.410
Why?
Cornea
3
2025
155
0.410
Why?
Biomarkers
9
2025
4227
0.410
Why?
Multimodal Imaging
2
2025
120
0.400
Why?
Corneal Transplantation
2
2025
17
0.400
Why?
Internet
4
2023
695
0.400
Why?
Glucocorticoids
4
2026
539
0.390
Why?
Commerce
2
2013
77
0.390
Why?
Vitreous Body
4
2022
116
0.390
Why?
Diabetes Mellitus
5
2024
1084
0.390
Why?
Fluocinolone Acetonide
2
2023
15
0.380
Why?
Smoking Prevention
1
2013
170
0.370
Why?
Tobacco Products
1
2013
89
0.360
Why?
Risk Factors
14
2025
10569
0.360
Why?
Macula Lutea
2
2023
18
0.360
Why?
Ophthalmologic Surgical Procedures
2
2025
90
0.360
Why?
Fundus Oculi
3
2025
87
0.340
Why?
Retinal Diseases
2
2023
94
0.340
Why?
Disease Notification
2
2011
16
0.340
Why?
Lens Capsule, Crystalline
2
2021
13
0.330
Why?
Complement Factor B
2
2022
106
0.310
Why?
Artificial Intelligence
2
2024
358
0.310
Why?
Treatment Outcome
12
2026
11341
0.300
Why?
Comorbidity
2
2011
1632
0.300
Why?
Tonometry, Ocular
3
2025
103
0.300
Why?
Eye Injuries
2
2021
53
0.300
Why?
Diabetes Mellitus, Type 2
4
2023
2587
0.280
Why?
Tertiary Care Centers
2
2026
185
0.280
Why?
Infant
13
2026
9849
0.270
Why?
Bangladesh
3
2022
60
0.260
Why?
Hepatitis A
2
2011
29
0.260
Why?
Healthcare Disparities
2
2025
693
0.260
Why?
West Nile virus
1
2007
40
0.260
Why?
Adult
24
2026
39754
0.250
Why?
Gestational Age
4
2026
970
0.250
Why?
Time Factors
7
2025
7008
0.250
Why?
Health Promotion
1
2013
760
0.250
Why?
Local Government
1
2006
25
0.250
Why?
Pars Planitis
1
2026
6
0.250
Why?
Restaurants
1
2006
22
0.240
Why?
Prospective Studies
7
2025
7845
0.240
Why?
Vision Disorders
3
2022
175
0.240
Why?
Chronic Disease
2
2011
1818
0.240
Why?
Keratoconjunctivitis
1
2026
11
0.240
Why?
Blepharitis
1
2026
9
0.240
Why?
Public Health Administration
1
2006
72
0.240
Why?
Scleritis
2
2025
28
0.240
Why?
Mass Screening
2
2024
1317
0.230
Why?
Retinal Degeneration
1
2026
40
0.230
Why?
Blindness
1
2026
50
0.230
Why?
Eye Proteins
1
2026
92
0.230
Why?
Visual Fields
1
2026
117
0.230
Why?
Chemokine CCL5
2
2023
42
0.230
Why?
Ciliary Body
1
2025
40
0.220
Why?
Pilocarpine
1
2025
16
0.220
Why?
Keratoconus
1
2025
23
0.220
Why?
Pemphigoid, Benign Mucous Membrane
1
2024
6
0.220
Why?
Withholding Treatment
1
2025
79
0.220
Why?
Occupational Stress
1
2025
43
0.210
Why?
Surgery, Plastic
1
2025
50
0.210
Why?
Quality of Life
5
2023
3068
0.210
Why?
Education, Distance
1
2025
60
0.210
Why?
Birth Weight
3
2022
520
0.210
Why?
Retinoblastoma
1
2024
50
0.210
Why?
Aberrometry
2
2021
9
0.210
Why?
Child
14
2026
22376
0.210
Why?
Young Adult
7
2026
13817
0.210
Why?
Optics and Photonics
2
2021
41
0.200
Why?
Disease Progression
4
2025
2851
0.200
Why?
Adolescent
12
2026
22135
0.200
Why?
Telemedicine
2
2024
919
0.200
Why?
Macular Edema
1
2023
48
0.190
Why?
Feasibility Studies
2
2024
1047
0.190
Why?
Postoperative Period
5
2025
351
0.190
Why?
Insulins
1
2023
38
0.190
Why?
Homosexuality, Male
2
2020
207
0.190
Why?
Job Satisfaction
1
2025
232
0.190
Why?
Eye Burns
1
2022
14
0.190
Why?
Vision, Low
1
2022
17
0.190
Why?
Cohort Studies
6
2022
5820
0.190
Why?
Outpatient Clinics, Hospital
1
2023
80
0.190
Why?
Endoscopy
1
2025
326
0.190
Why?
Eyelid Diseases
1
2022
23
0.190
Why?
Compartment Syndromes
1
2022
36
0.180
Why?
Odds Ratio
4
2019
1052
0.180
Why?
Incidence
5
2022
2828
0.180
Why?
Eyeglasses
1
2022
24
0.180
Why?
Corneal Ulcer
1
2022
20
0.180
Why?
Retinal Perforations
1
2022
18
0.180
Why?
Clothing
1
2022
22
0.180
Why?
Infant, Newborn
6
2026
6315
0.180
Why?
Patient Satisfaction
2
2024
692
0.170
Why?
Ocular Hypertension
1
2022
70
0.170
Why?
Weapons
1
2021
9
0.170
Why?
Civil Disorders
1
2021
8
0.170
Why?
Political Activism
1
2021
9
0.170
Why?
Refractive Surgical Procedures
1
2021
7
0.170
Why?
Neonatal Screening
1
2022
174
0.170
Why?
Eye Banks
1
2020
7
0.170
Why?
Child, Preschool
10
2026
11599
0.170
Why?
Sickness Impact Profile
1
2020
58
0.170
Why?
Glaucoma Drainage Implants
1
2021
46
0.160
Why?
Posterior Capsular Rupture, Ocular
1
2020
6
0.160
Why?
Perception
2
2021
370
0.160
Why?
Glycation End Products, Advanced
1
2021
86
0.160
Why?
Health Services Accessibility
2
2026
1066
0.160
Why?
Accidents, Traffic
1
2022
190
0.160
Why?
SEER Program
2
2011
220
0.160
Why?
Neurodegenerative Diseases
1
2022
140
0.160
Why?
Scleral Buckling
1
2019
15
0.160
Why?
Retinal Hemorrhage
1
2019
21
0.160
Why?
Vitreoretinopathy, Proliferative
1
2019
13
0.150
Why?
Hepatitis C
1
2022
249
0.150
Why?
Language
1
2023
320
0.150
Why?
Legislation, Drug
1
2020
77
0.150
Why?
Protective Factors
1
2019
102
0.150
Why?
Health Status Disparities
1
2023
313
0.150
Why?
Head Injuries, Closed
1
2019
49
0.150
Why?
Oculomotor Muscles
1
2020
85
0.150
Why?
MAP Kinase Kinase 1
1
2019
74
0.150
Why?
Risk Assessment
3
2019
3533
0.150
Why?
Complement Membrane Attack Complex
1
2019
38
0.150
Why?
Specialization
1
2020
134
0.150
Why?
Complement C3a
1
2019
41
0.150
Why?
Cardiovascular Diseases
1
2011
2095
0.150
Why?
Uveitis, Posterior
1
2019
12
0.150
Why?
Accreditation
1
2019
97
0.150
Why?
Refugees
1
2020
82
0.140
Why?
Choroidal Neovascularization
1
2019
56
0.140
Why?
Medical Marijuana
1
2020
122
0.140
Why?
Patient Care
1
2019
119
0.140
Why?
Case-Control Studies
3
2022
3601
0.140
Why?
Down Syndrome
1
2025
523
0.140
Why?
Glaucoma, Angle-Closure
1
2018
22
0.140
Why?
Curriculum
1
2025
1032
0.140
Why?
Infant, Premature
1
2022
606
0.140
Why?
Health Services Needs and Demand
1
2020
277
0.140
Why?
Trabecular Meshwork
1
2018
80
0.130
Why?
Sexually Transmitted Diseases
3
2004
166
0.130
Why?
Proto-Oncogene Proteins B-raf
1
2019
227
0.130
Why?
Marijuana Smoking
1
2020
255
0.120
Why?
Marijuana Use
1
2020
214
0.120
Why?
Clinical Competence
2
2025
1218
0.120
Why?
Logistic Models
2
2019
2088
0.120
Why?
Recovery of Function
1
2019
691
0.110
Why?
Disease Management
1
2019
636
0.110
Why?
Population Surveillance
2
2011
490
0.110
Why?
Aging
1
2026
1963
0.110
Why?
Inflammation
3
2023
2883
0.110
Why?
Proportional Hazards Models
2
2024
1286
0.110
Why?
Education, Medical, Graduate
1
2019
543
0.110
Why?
Disease Outbreaks
2
2008
423
0.100
Why?
Retinal Pigment Epithelium
2
2024
78
0.100
Why?
Condoms
2
2004
98
0.100
Why?
Physicians
1
2022
925
0.100
Why?
Intravitreal Injections
2
2026
70
0.100
Why?
Research Design
1
2019
1113
0.090
Why?
Sexual Behavior
4
2004
485
0.090
Why?
Melanoma
1
2019
797
0.090
Why?
Medicare
2
2024
813
0.090
Why?
Skin Neoplasms
1
2019
854
0.090
Why?
Axial Length, Eye
2
2024
16
0.090
Why?
Hypoglycemic Agents
1
2021
1388
0.090
Why?
Immunologic Factors
2
2024
255
0.080
Why?
Diagnostic Errors
1
2011
175
0.080
Why?
Primary Prevention
1
2011
195
0.080
Why?
Shellfish Poisoning
1
2009
1
0.080
Why?
Vibrio Infections
1
2009
2
0.080
Why?
Shellfish
1
2009
6
0.080
Why?
Food Industry
1
2009
8
0.080
Why?
Food Microbiology
1
2009
73
0.070
Why?
Sex Factors
2
2025
2066
0.070
Why?
Cause of Death
1
2011
457
0.070
Why?
Kaplan-Meier Estimate
1
2011
917
0.070
Why?
Internship and Residency
1
2019
1233
0.070
Why?
Mortality
1
2011
360
0.070
Why?
Academic Medical Centers
2
2022
534
0.070
Why?
Cryptosporidiosis
1
2008
22
0.070
Why?
Antineoplastic Agents
1
2019
2171
0.070
Why?
Anti-Inflammatory Agents
2
2022
477
0.070
Why?
Disease Reservoirs
1
2007
25
0.070
Why?
Maternal-Child Health Centers
1
2007
8
0.070
Why?
Culicidae
1
2007
33
0.070
Why?
Sentinel Surveillance
1
2007
46
0.070
Why?
Gastroenteritis
1
2008
62
0.070
Why?
Health Services Administration
1
2007
8
0.070
Why?
Relief Work
1
2007
18
0.070
Why?
Chickens
1
2007
191
0.060
Why?
Telephone
1
2008
171
0.060
Why?
Enzyme-Linked Immunosorbent Assay
2
2019
850
0.060
Why?
Birds
1
2007
91
0.060
Why?
Geography
1
2007
201
0.060
Why?
Horses
1
2007
204
0.060
Why?
Health Care Surveys
1
2008
533
0.060
Why?
Diabetes Mellitus, Type 1
1
2023
3833
0.060
Why?
Visual Field Tests
1
2026
34
0.060
Why?
Disasters
1
2007
99
0.060
Why?
Smoking
1
2013
1552
0.060
Why?
Environment
1
2007
306
0.060
Why?
Immunoglobulins
1
2006
162
0.060
Why?
Immunization Programs
1
2007
190
0.060
Why?
Predictive Value of Tests
1
2011
2083
0.060
Why?
Bevacizumab
1
2026
141
0.060
Why?
Databases, Factual
1
2011
1452
0.060
Why?
Corneal Topography
1
2025
25
0.060
Why?
Miotics
1
2025
6
0.060
Why?
Muscarinic Agonists
1
2025
14
0.060
Why?
Azathioprine
1
2025
48
0.060
Why?
Adalimumab
1
2025
54
0.060
Why?
Ganglionic Stimulants
1
2005
15
0.060
Why?
Tomography
1
2025
45
0.060
Why?
Lubricant Eye Drops
1
2024
9
0.060
Why?
Ontario
1
2024
94
0.050
Why?
Infliximab
1
2025
108
0.050
Why?
Mycophenolic Acid
1
2025
120
0.050
Why?
Conjunctivitis
1
2024
30
0.050
Why?
Retinal Neoplasms
1
2024
42
0.050
Why?
Needs Assessment
1
2007
389
0.050
Why?
Rwanda
1
2024
33
0.050
Why?
Capacity Building
1
2024
59
0.050
Why?
Ophthalmic Solutions
1
2024
79
0.050
Why?
Patient Discharge
1
2011
937
0.050
Why?
Attitude to Health
1
2007
435
0.050
Why?
Methotrexate
1
2025
238
0.050
Why?
Vision Tests
1
2023
22
0.050
Why?
Hospitals, County
1
2023
10
0.050
Why?
Pulmonary Disease, Chronic Obstructive
1
2011
1065
0.050
Why?
Observational Studies as Topic
1
2023
126
0.050
Why?
Health Surveys
2
2021
506
0.050
Why?
Postoperative Care
1
2025
276
0.050
Why?
Tobacco Use Disorder
1
2005
223
0.050
Why?
Interleukin-4
1
2023
212
0.050
Why?
Complement Factor I
1
2022
12
0.050
Why?
Electronic Health Records
1
2011
1165
0.050
Why?
Mentors
1
2024
211
0.050
Why?
Gonorrhea
1
2003
65
0.050
Why?
Global Health
1
2025
388
0.050
Why?
Aqueous Humor
1
2022
38
0.050
Why?
Orbit
1
2022
66
0.050
Why?
Hospitals, Pediatric
1
2026
545
0.050
Why?
Phenotype
2
2022
3160
0.050
Why?
Alanine Transaminase
1
2022
147
0.050
Why?
Drug Implants
1
2022
83
0.050
Why?
Cluster Analysis
1
2023
527
0.050
Why?
Nicotine
1
2005
331
0.040
Why?
Communication Barriers
1
2023
123
0.040
Why?
Reference Standards
1
2022
181
0.040
Why?
Capsulorhexis
1
2021
8
0.040
Why?
Albumins
1
2022
114
0.040
Why?
Safety-net Providers
1
2023
124
0.040
Why?
Morbidity
1
2022
319
0.040
Why?
Fibrinogen
1
2022
179
0.040
Why?
Dissent and Disputes
1
2021
18
0.040
Why?
Retinal Ganglion Cells
1
2022
121
0.040
Why?
Hepacivirus
1
2022
232
0.040
Why?
Intraoperative Period
1
2020
68
0.040
Why?
Smoking Cessation
1
2005
434
0.040
Why?
Crowding
1
2021
37
0.040
Why?
Biometry
1
2021
68
0.040
Why?
Myotomy
1
2020
14
0.040
Why?
Myanmar
1
2020
6
0.040
Why?
Risk-Taking
1
2003
332
0.040
Why?
Rupture
1
2020
86
0.040
Why?
Immunosuppressive Agents
1
2025
842
0.040
Why?
Vision, Binocular
1
2020
47
0.040
Why?
Adrenal Cortex Hormones
1
2023
498
0.040
Why?
Eye Movements
1
2020
92
0.040
Why?
Survival Rate
1
2024
2003
0.040
Why?
HIV
1
2020
247
0.040
Why?
Health Education
1
2003
355
0.040
Why?
Chromatography, Liquid
1
2021
450
0.040
Why?
Canada
1
2020
422
0.040
Why?
C-Reactive Protein
1
2021
417
0.040
Why?
Remission, Spontaneous
1
2019
39
0.040
Why?
Pilot Projects
1
2024
1830
0.040
Why?
Microscopy, Acoustic
1
2018
9
0.040
Why?
Attitude
1
2021
254
0.040
Why?
Ophthalmoscopy
1
2018
38
0.040
Why?
Pyrimidinones
1
2019
127
0.040
Why?
Preoperative Period
1
2019
144
0.040
Why?
Clinical Trials as Topic
1
2023
1037
0.040
Why?
Exfoliation Syndrome
1
2018
10
0.030
Why?
Corneal Pachymetry
1
2018
16
0.030
Why?
Ambulatory Care
1
2023
588
0.030
Why?
Pseudophakia
1
2018
22
0.030
Why?
Circadian Rhythm
1
2023
516
0.030
Why?
Tandem Mass Spectrometry
1
2021
567
0.030
Why?
Disease-Free Survival
1
2019
727
0.030
Why?
Severity of Illness Index
1
2026
2905
0.030
Why?
Physical Examination
1
2019
234
0.030
Why?
Prosthesis Design
1
2020
349
0.030
Why?
Cost-Benefit Analysis
1
2020
614
0.030
Why?
Longitudinal Studies
1
2025
2930
0.030
Why?
Ambulatory Care Facilities
3
2004
257
0.030
Why?
Stents
1
2021
542
0.030
Why?
Delivery of Health Care
1
2024
936
0.030
Why?
Equipment Design
1
2018
530
0.030
Why?
Referral and Consultation
1
2022
823
0.030
Why?
Sex Characteristics
1
2022
782
0.030
Why?
Mental Health
1
2022
767
0.030
Why?
Reproducibility of Results
1
2023
3362
0.030
Why?
Sleep
1
2023
903
0.030
Why?
Multivariate Analysis
1
2019
1493
0.030
Why?
Program Evaluation
2
2011
938
0.030
Why?
Anxiety
1
2022
1088
0.030
Why?
Proteins
1
2020
1016
0.030
Why?
Anti-Bacterial Agents
1
2024
1892
0.030
Why?
Child Abuse
1
2019
548
0.030
Why?
Proteomics
1
2020
1167
0.020
Why?
T-Lymphocytes
1
2022
2034
0.020
Why?
Protein Kinase Inhibitors
1
2019
976
0.020
Why?
Depression
1
2022
1501
0.020
Why?
Pandemics
1
2021
1660
0.020
Why?
Animals
3
2009
37904
0.020
Why?
Legionellosis
1
2011
2
0.020
Why?
Blood Glucose
1
2021
2321
0.020
Why?
Prognosis
1
2019
4159
0.020
Why?
Medical Audit
1
2011
73
0.020
Why?
Whooping Cough
1
2011
55
0.020
Why?
Haemophilus Infections
1
2011
40
0.020
Why?
Hospitals, Urban
1
2011
137
0.020
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2019
1833
0.020
Why?
International Classification of Diseases
1
2011
140
0.020
Why?
Cryptosporidium
1
2008
14
0.020
Why?
Caliciviridae Infections
1
2008
18
0.020
Why?
Norovirus
1
2008
22
0.020
Why?
Aid to Families with Dependent Children
1
2007
3
0.020
Why?
Residence Characteristics
1
2011
376
0.020
Why?
Faculty
1
2008
147
0.020
Why?
Diphtheria-Tetanus-acellular Pertussis Vaccines
1
2007
91
0.020
Why?
Medically Uninsured
1
2007
129
0.020
Why?
Family Characteristics
1
2008
196
0.020
Why?
Sensitivity and Specificity
1
2011
1976
0.010
Why?
Pharmaceutical Preparations
1
2007
170
0.010
Why?
Guideline Adherence
1
2009
561
0.010
Why?
Maryland
1
2005
62
0.010
Why?
Administration, Topical
1
2005
152
0.010
Why?
Urban Health Services
1
2004
68
0.010
Why?
Acute Disease
1
2007
994
0.010
Why?
Office Visits
1
2003
91
0.010
Why?
Syphilis
1
2003
33
0.010
Why?
Administration, Oral
1
2005
834
0.010
Why?
Antiretroviral Therapy, Highly Active
1
2003
277
0.010
Why?
Risk
1
2004
897
0.010
Why?
Mothers
1
2007
768
0.010
Why?
Urban Population
1
2004
481
0.010
Why?
HIV Infections
1
2003
3031
0.000
Why?
Patnaik's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)